Immune modulation as a consequence of SARS-CoV-2 infection
Erroneous immune responses in COVID-19 could have detrimental effects, which makes investigation of immune network underlying COVID-19 pathogenesis a requisite. This study aimed to investigate COVID-19 related alterations within the frame of innate and adaptive immunity. Thirty-four patients clinica...
Saved in:
Published in | Frontiers in immunology Vol. 13; p. 954391 |
---|---|
Main Authors | , , , , , , , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
Switzerland
Frontiers Media S.A
30.08.2022
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | Erroneous immune responses in COVID-19 could have detrimental effects, which makes investigation of immune network underlying COVID-19 pathogenesis a requisite. This study aimed to investigate COVID-19 related alterations within the frame of innate and adaptive immunity. Thirty-four patients clinically diagnosed with mild, moderate and severe COVID-19 disease were enrolled in this study. Decreased ILC1 and increased ILC2 subsets were detected in mild and moderate patients compared to healthy controls. NK cell subsets and cytotoxic capacity of NK cells were decreased in severe patients. Moreover, CD3
T cells were reduced in severe patients and a negative correlation was found between CD3
T cells and D-dimer levels. Likewise, moderate and severe patients showed diminished CD3
CD8
T cells. Unlike T and NK cells, plasmablast and plasma cells were elevated in patients and IgG and IgA levels were particularly increased in severe patients. Severe patients also showed elevated serum levels of pro-inflammatory cytokines such as TNF-α, IL-6 and IL-8, reduced intracellular IFN-γ and increased intracellular IL-10 levels. Our findings emphasize that SARS-CoV-2 infection significantly alters immune responses and innate and acquired immunity are differentially modulated in line with the clinical severity of the disease. Elevation of IL-10 levels in NK cells and reduction of CD3
and CD8
T cells in severe patients might be considered as a protective response against the harmful effect of cytokine storm seen in COVID-19. |
---|---|
Bibliography: | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 Reviewed by: Nihal Gökmen, Ege University, Turkey; Nejla Zeynep Kubilay, Vanderbilt University, United States ; Elif Tukenmez Tigen, Marmara University, Turkey Edited by: Julie Olson, University of Minnesota Twin Cities, United States These authors have contributed equally to this work This article was submitted to Viral Immunology, a section of the journal Frontiers in Immunology |
ISSN: | 1664-3224 1664-3224 |
DOI: | 10.3389/fimmu.2022.954391 |